|
BABE 2019 Report
The 10th World Congress on Bioavailability and Bioequivalence which was held during April 08-09, 2019 at Radisson Blu Hotel Abu Dhabi Yas Island with the theme of “The rationale of BA/BE studies for Pharmaceutical business and Public health” which got a magnificent response. With the support of the organizing committee members, editorial board members and impressive presentations of all participants this conference became glorious.
The speakers from different places of the world have given the multiple presentations on the major session like Bioavailability, Bioequivalence, Clinical Research, Drug Discovery, Pharmacology, and Pharmaceutical Formulations.
BABE 2019 would like to convey the great appreciation for Dr. Said Abdel Karim Abdel Hamid Mohamed from SEHA-Ambulatory Healthcare Services, UAE for moderating the event and to Dr. Royida Al Marastani from SEHA-Ambulatory Healthcare Services, UAE, Dr. Heyam Saad Ali, from Dubai Pharmacy College, UAE as Keynote speakers. We would like to extend our thanks to Royida Al Marastani and Said Abdel Karim Abdel Hamid Mohamed for conducting the workshops on “Drug interactions affecting drug bioavailability” and “Assessment of antimicrobial agents in stewardship program” respectively.
BABE 2019 would also like to thank the following speakers for their splendid presentations on their research.
- Sudhir Kumar Sharma, New York University Abu Dhabi, UAE
- Amal Ahmed Abdel Nabbi Hassan, Dubai Pharmacy College, UAE
- Said Abdel Karim Abdel Hamid Mohamed, SEHA-Ambulatory Healthcare Services, UAE
- Rana Mhd Farid Sammour, Dubai Pharmacy College, UAE
With the successful completion of 10th World Congress on Bioavailability and Bioequivalence we are happy to announce our upcoming conference in BABE series i.e., 11th World Congress on Bioavailability and Bioequivalence during March 11-12, 2020 at Dubai, UAE
|
|
Expert Presentations
|
Name